CALL/AMGEN/500/0.1/21.06.24 | Market Closed - BOERSE MUENCHEN 02:25:29 2024-05-17 pm EDT | ||
| 0.008 EUR | 0.00% |
|
| 1 month | -33.33% | ||
| 3 months | +166.67% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-17 | 0.008 | 0.00% |
| 24-05-16 | 0.008 | 0.00% |
| 24-05-15 | 0.008 | +14.29% |
| 24-05-14 | 0.007 | +16.67% |
| 24-05-13 | 0.006 | -25.00% |
Real-time BOERSE MUENCHEN
Last update May 17, 2024 at 02:25 pm EDT
More quotesStatic data
| Product type | Warrant Plain-Vanilla |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Goldman Sachs |
| WKN | GG1XEG |
| ISIN | DE000GG1XEG4 |
| Date issued | 2024-01-05 |
| Strike | 500 $ |
| Maturity | 2024-06-21 (35 Days) |
| Parity | 10 : 1 |
| Emission price | 0.01 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.025 € |
|---|---|
| Lowest since issue | 0.002 € |
| Spread | 0.15 € |
| Spread % | 93.75% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
312.5
USD
Average target price
314.1
USD
Spread / Average Target
+0.51%
- Stock Market
- Warrants
- Warrant
